Cargando…

The King-Devick test of rapid number naming for concussion detection: meta-analysis and systematic review of the literature

BACKGROUND: Vision encompasses a large component of the brain's pathways, yet is not represented in current sideline testing. OBJECTIVES: We performed a meta-analysis of published data for a vision-based test of rapid number naming (King-Devick [K-D] test). STUDIES & METHODS: Pooled and met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galetta, Kristin M, Liu, Mengling, Leong, Danielle F, Ventura, Rachel E, Galetta, Steven L, Balcer, Laura J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114024/ https://www.ncbi.nlm.nih.gov/pubmed/30202552 http://dx.doi.org/10.2217/cnc.15.8

Ejemplares similares

Rapid number naming in chronic concussion: eye movements in the King–Devick test
por: Rizzo, John‐Ross, et al.
Publicado: (2016)

King-Devick Test Performance and Cognitive Dysfunction after Concussion: A Pilot Eye Movement Study
por: Gold, Doria M., et al.
Publicado: (2021)

On-field assessment of concussion: clinical utility of the King-Devick test
por: Legarreta, Andrew D, et al.
Publicado: (2019)

Characteristics of the King-Devick test in the assessment of concussed patients in the subacute and later stages after injury
por: Subotic, Arsenije, et al.
Publicado: (2017)

Saccadic Latency Measures on Oculomotor Tracking and King Devick Testing Performance Measures in Pediatric Concussion Patients
por: Sarva, Saikaashyap, et al.
Publicado: (2022)

Correlating the King-Devick Test With Vestibular/Ocular Motor Screening in Adolescent Patients With Concussion: A Pilot Study
por: Russell-Giller, Shira, et al.
Publicado: (2018)

Evaluation and Utility of the King-Devick With Integrated Eye Tracking as a Diagnostic Tool for Sport-Related Concussion
por: Hecimovich, Mark, et al.
Publicado: (2022)

Sleep-deprived residents and rapid picture naming performance using the Mobile Universal Lexicon Evaluation System (MULES) test
por: Conway, Jenna, et al.
Publicado: (2021)

Post-traumatic headache: the use of the sport concussion assessment tool (SCAT-3) as a predictor of post-concussion recovery
por: Begasse de Dhaem, Olivia, et al.
Publicado: (2017)

Use of the King-Devick Variable Color Contrast Sensitivity Chart to differentiate stages of age-related macular degeneration
por: Ittiara, Shaun, et al.
Publicado: (2020)

Annual Baseline King-Devick Oculomotor Function Testing Is Needed Due to Scores Varying by Age
por: Gallagher, Dearbhla, et al.
Publicado: (2021)

Trends in concussion mechanism of injury during the COVID-19 pandemic
por: Schaffer, Olivia, et al.
Publicado: (2023)

Developmental Eye Movement (DEM) and King-Devick (K-D) Performance in Multiple Sclerosis
por: Gil-Casas, Amparo, et al.
Publicado: (2022)

Correspondence regarding: Post-traumatic headache: the use of the sport concussion assessment tool (SCAT-3) as a predictor of post-concussion recovery
por: Khazaei, Salman, et al.
Publicado: (2017)

Precision Concussion Management: Approaches to Quantifying Head Injury Severity and Recovery
por: de Souza, Daniel N., et al.
Publicado: (2023)

The Neurological Complications of Nutritional Deficiency following Bariatric Surgery
por: Becker, Danielle A., et al.
Publicado: (2012)

Computer-based Eye-tracking Analysis of King-Devick Test Differentiates Persons With Idiopathic Normal Pressure Hydrocephalus From Cognitively Unimpaired
por: Lehtola, Juha-Matti, et al.
Publicado: (2022)

Cerebrospinal fluid in COVID-19: A systematic review of the literature
por: Lewis, Ariane, et al.
Publicado: (2021)

Cerebrospinal fluid findings in patients with seizure in the setting of COVID-19: A review of the literature
por: Carroll, Elizabeth, et al.
Publicado: (2021)

The names of kings : the parisian laboring poor in the eighteenth century /
por: Kaplow, Jeffry
Publicado: (1972)

Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab
por: Petrillo, Jennifer, et al.
Publicado: (2019)

Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life
por: Chahin, Salim, et al.
Publicado: (2015)

The psychosocial implications of COVID-19 for a neurology program in a pandemic epicenter
por: Croll, Leah, et al.
Publicado: (2020)

Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review
por: Lewis, Ariane, et al.
Publicado: (2021)

Apparent lack of association of COVID-19 vaccination with Herpes Zoster
por: Patil, Sachi A., et al.
Publicado: (2022)

Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
por: Bose, Gauruv, et al.
Publicado: (2021)

Sprinting into the field of neuro-ophthalmology from the streets of Brooklyn
por: Galetta, Steven L.
Publicado: (2020)

Alemtuzumab improves contrast sensitivity in patients with relapsing–remitting multiple sclerosis
por: Graves, Jennifer, et al.
Publicado: (2013)

Acute optic neuritis: Unmet clinical needs and model for new therapies
por: Galetta, Steven L., et al.
Publicado: (2015)

Neuro-ophthalmology in the Era of COVID-19: Future Implications of a Public Health Crisis
por: Grossman, Scott N., et al.
Publicado: (2020)

Advances in Lung Cancer Therapy
por: Galetta, Domenico
Publicado: (2023)

Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis
por: Balcer, Laura J, et al.
Publicado: (2017)

Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE
por: Perumal, Jai, et al.
Publicado: (2019)

Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing–Remitting Multiple Sclerosis: STRIVE Data Analysis
por: Perumal, Jai, et al.
Publicado: (2023)

An inflammatory milieu: Optic perineuritis, retroperitoneal fibrosis, and giant cell arteritis
por: Gold, Doria M., et al.
Publicado: (2019)

Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19)
por: Gold, Doria M., et al.
Publicado: (2021)

Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19
por: Valdes, Eduard, et al.
Publicado: (2022)

Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study
por: Perumal, Jai, et al.
Publicado: (2022)

Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study
por: Perumal, Jai, et al.
Publicado: (2023)

Treatment with Zinc is Associated with Reduced In-Hospital Mortality Among COVID-19 Patients: A Multi-Center Cohort Study
por: frontera, Jennifer A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_docb8u2rgovp4htf2tmev4stq8